These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 11160737)
1. Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. Li M; Yang C; Compans RW J Virol; 2001 Mar; 75(5):2337-44. PubMed ID: 11160737 [TBL] [Abstract][Full Text] [Related]
2. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion. Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949 [TBL] [Abstract][Full Text] [Related]
3. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry. Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. Yang C; Compans RW J Virol; 1996 Jan; 70(1):248-54. PubMed ID: 8523533 [TBL] [Abstract][Full Text] [Related]
5. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. Christodoulopoulos I; Cannon PM J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity. Yang C; Compans RW J Virol; 1997 Nov; 71(11):8490-6. PubMed ID: 9343206 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic R-peptide of murine leukemia virus envelope protein negatively regulates its interaction with the cell surface receptor. Kubo Y; Izumida M; Togawa K; Zhang F; Hayashi H Virology; 2019 Jun; 532():82-87. PubMed ID: 31035110 [TBL] [Abstract][Full Text] [Related]
8. Coreceptor-dependent inhibition of the cell fusion activity of simian immunodeficiency virus Env proteins. Yang C; Yang Q; Compans RW J Virol; 2000 Jul; 74(13):6217-22. PubMed ID: 10846110 [TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein. Kubo Y; Amanuma H J Gen Virol; 2003 Aug; 84(Pt 8):2253-2257. PubMed ID: 12867658 [TBL] [Abstract][Full Text] [Related]
10. Cell signaling through the protein kinases cAMP-dependent protein kinase, protein kinase Cepsilon, and RAF-1 regulates amphotropic murine leukemia virus envelope protein-induced syncytium formation. Wang W; Jobbagy Z; Bird TH; Eiden MV; Anderson WB J Biol Chem; 2005 Apr; 280(17):16772-83. PubMed ID: 15741175 [TBL] [Abstract][Full Text] [Related]
11. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein. Thomas A; Gray KD; Roth MJ Virology; 1997 Jan; 227(2):305-13. PubMed ID: 9018129 [TBL] [Abstract][Full Text] [Related]
12. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239 [TBL] [Abstract][Full Text] [Related]
13. Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression. Li M; Yang C; Tong S; Weidmann A; Compans RW J Virol; 2002 Dec; 76(23):11845-52. PubMed ID: 12414927 [TBL] [Abstract][Full Text] [Related]
14. N-Linked glycosylation is required for XC cell-specific syncytium formation by the R peptide-containing envelope protein of ecotropic murine leukemia viruses. Kubo Y; Ishimoto A; Amanuma H J Virol; 2003 Jul; 77(13):7510-6. PubMed ID: 12805451 [TBL] [Abstract][Full Text] [Related]
15. Involvement of the C-terminal disulfide-bonded loop of murine leukemia virus SU protein in a postbinding step critical for viral entry. Burkhart MD; D'Agostino P; Kayman SC; Pinter A J Virol; 2005 Jun; 79(12):7868-76. PubMed ID: 15919941 [TBL] [Abstract][Full Text] [Related]
16. Identification of R-peptides in envelope proteins of C-type retroviruses. Bobkova M; Stitz J; Engelstädter M; Cichutek K; Buchholz CJ J Gen Virol; 2002 Sep; 83(Pt 9):2241-2246. PubMed ID: 12185279 [TBL] [Abstract][Full Text] [Related]
17. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Spies CP; Compans RW Virology; 1994 Aug; 203(1):8-19. PubMed ID: 8030287 [TBL] [Abstract][Full Text] [Related]
18. Cell fusion induced by the murine leukemia virus envelope glycoprotein. Jones JS; Risser R J Virol; 1993 Jan; 67(1):67-74. PubMed ID: 8416389 [TBL] [Abstract][Full Text] [Related]
19. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations. Kiernan RE; Freed EO J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695 [TBL] [Abstract][Full Text] [Related]
20. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain. Taylor GM; Sanders DA Virology; 2003 Aug; 312(2):295-305. PubMed ID: 12919735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]